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Purpose: To evaluate the selectivity and strength of intraoperative trypan blue staining
during removal of epiretinal membranes (ERMs) and the internal limiting membrane.
Methods: Based on intraoperative videos, 51 consecutive chromovitrectomies in 51
patients with macular holes, macular pucker, vitreomacular traction syndromes, or
persistent macular edema were retrospectively studied. Fifteen subjects underwent trypan
blue, 14 indocyanine green, and 22 brilliant blue G chromovitrectomy. The main outcome
measure was the color contrast between stained internal limiting membrane or ERM
and the underlying unstained tissue by means of objective, quantitative, semiautomated
chromaticity difference measurements.
Results: Trypan blue stains both ERM and the internal limiting membrane (average
chromaticity scores 8.51 and 7.09, respectively; P = 0.48). Internal limiting membrane
chromaticity scores were similar for trypan blue (7.09) and brilliant blue G (6.81; P = 0.71)
but clearly higher for indocyanine green (15.81; P = 2.45 · 10−5).
Conclusion: Under the premises of our study, trypan blue stains both ERM and the
internal limiting membrane. Trypan blue’s staining capacity of the internal limiting mem-
brane is similar to that of brilliant blue G but significantly inferior compared with indocyanine
green. Trypan blue, thus, represents a useful vital dye for chromovitrectomy, particularly in
the presence of ERM, where it allows a sequential approach.
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Anteroposterior and tangential posterior pole vitre-oretinal traction is causal in the formation of a mul-
titude of macular pathologies, including macular holes,
vitreomacular traction syndrome, persistent macular
edema, and macular pucker.1 Common clinical char-
acteristics of these conditions include visual loss and
metamorphopsias.
A fundamental approach to diseases based on
vitreoretinal traction has become attainable with the
introduction of pars plana vitrectomy.2 However,
mechanical vitrectomy is often incomplete. Even if
epiretinal membranes (ERMs) are removed thoroughly,
residual cortical vitreous attached to the internal lim-
iting membrane (ILM) may account for sustained trac-
tion.1 Although originally regarded as an unintentional
side effect of ERM removal,3 peeling of the ILM has
been demonstrated to improve anatomical outcomes
through a more complete release of tractional forces
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and inhibition of reproliferation of fibrous astrocytes,4
resulting in higher rates of macular hole closure and
improved visual outcomes.5–8
Both the pellucid and highly delicate ERM and ILM
may be technically difficult to detach from
the substrate. As a result, damage to the underlying
retina in the form of intraretinal hemorrhages, central
retinal breaks, and functional retinal injury may
ensue.9–11 The completeness of ILM removal is also
difficult to ensure. To improve safety and complete-
ness of ERM and ILM removal, many surgeons rely
on the application of vital dyes to increase the visibil-
ity of the target tissue, an approach frequently referred
to as chromovitrectomy.12 If both ERM and the ILM
are intended to be removed, one or several dyes may
be used sequentially to differentiate the different tissue
layers. A great deal of disarray exists, however,
regarding which biostain to choose for ILM removal
and for sequential macular surgery. A suitable vital dye
for ILM peeling would combine strong ILM staining
with a favorable safety profile and approval status. For
sequential interventions, a strong additional affinity to
ERM would be desirable. Trypan blue (TB) has been
proposed for ERM staining, but uncertainty revolves
around its affinity to the ILM.13
Materials and Methods
In a retrospective clinical case series, we analyzed
51 consecutive chromovitrectomy interventions in 51
patients with macular holes, macular pucker, persistent
macular edema, and vitreomacular traction syndrome.
Twenty-four right eyes and 27 left eyes were included.
Patient age ranged from 47 years to 89 years (median
74.1 years). Twenty-four patients were women, 27
were men. Four patients were phakic and 27 were
pseudophakic, and in 20 interventions, a phacoemulsi-
fication and an insertion of a posterior chamber
intraocular lens into the capsular bag preceded chro-
movitrectomy. Exclusion criteria included patients
younger than 18 years, technically poor video quality,
and previous chromovitrectomies within the preceding
6 months.
All patients underwent routine 23-gauge vitrec-
tomy under local anesthesia, performed by 4 sur-
geons (P.B.H., S.G.P., T.J., and U.S.) at 2 centers
(Basel, Switzerland; Linz, Austria) using the OS3
vitrectomy system (Oertli, Berneck, Switzerland) in
combination with a Photon II light source (Syner-
getics, O’Fallon, MO).
The choice of the vital dye was based on the
preference of the individual surgeon. After complete
posterior vitreous detachment and vitrectomy, one of
three vital dyes was injected into the vitreous cavity:
• Trypan blue 0.15% was taken from ready-to-use
0.5-mL syringes stored at 4°C (MembraneBlue;
DORC International BV, Zuidland, the Netherlands).
The complete content of the syringe was injected
under balanced salt solution (BSS) and removed after
10 seconds.
• Brilliant blue G (BBG) 0.025% from ready-to-use
0.5-mL vials stored at room temperature (Brilliant
Peel; Geuder AG, Heidelberg, Germany) was instilled
completely under BSS with immediate washout.
• Indocyanine green (ICG) 1.25% was prepared as an
isoosmolar solution stored at room temperature and
a volume of 0.5 mL was applied intravitreally with
clearance occurring after 60 seconds (ICG Pulsion;
Pulsion Medical Systems AG, Munich, Germany).
Membrane removal recordings were performed as
described previously.14 Briefly, all interventions
were recorded using a Medlife Trio Digital Camera
in connection with a Medlife Mind Stream Digital
Recorder and an Opmi Visu 200 Ophthalmic Micro-
scope (all Carl Zeiss Meditec, Jena, Germany). Expo-
sure and calibration alignments were routinely
performed.
The video sequences were viewed and analyzed
postoperatively using a custom-made software tool-
programmed in MATLAB (Version R2007b, The
MathWorks, Inc., Natick, MA) as described earlier.14
Frames displaying good image quality were selected,
and regions of interest (ROIs) representing maximum
contrast were signaled within the temporal vascular
arcades under the supervision of a vitreoretinal sur-
geon (P.B.H.). For classification of ERM versus
ILM, all videos were reviewed with the surgeon.
Allocation of a frame to either the ERM or ILM
group is, thus, a representation of the surgeon’s clin-
ical intraoperative judgment, mainly based on mor-
phologic appearance and order of peeling events.
Histologic confirmation was not available because
of the retrospective nature of the study. For contrast
calculation, two distinct methods were used: In the
single image method, one ROI was selected in an
area with maximally stained ILM and compared with
another adjacent ROI of similar dimensions in the
same image in an area where the ILM had already
been removed during the course of the procedure. In
the multiple image method, an area with maximum
staining was selected and the same ROI was assessed
at different points in time, before and after ILM
removal. In total, 317 measurements were per-
formed: 84 based on the single image method and
233 measurements using the multiple image method.
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Equivalence of both methods had been described
previously,14 allowing pooling of data.
To quantitatively compare the perceived color
contrast of the selected ROIs, the software first
calculated the average color within each ROI. The
perceived color contrast in the 2 regions was
then determined by projecting the 2 averaged colors
into the CIE 1976 (L*,a*,b*) color space. In the
CIELAB color space, changes of the same visual
importance result in the same color space distance
(Euclidean distance). The Euclidean distance is
therefore a direct measure for perceivable visual
color difference.14 To assure independence of light-
ing variations, the Euclidean distance was only cal-
culated over the chromaticity components a* and b*,
omitting the lightness L*.
Statistical analysis was performed with the software
package R Version 2.11.1.15 Normality of the distri-
butions was assured with the Kolmogorov–Smirnov
test, and a t-test was used to assess significance. To
compare subgroup mean values, one-way analyses of
variance were performed. A P value , 0.05 was con-
sidered significant.
At all times, the tenets of the Declaration of Helsinki
were observed. The protocol was approved by the
local ethics committee.
Results
A clinically useful staining, sufficient for ERM and/
or ILM removal, was observed in all interventions
with the dye of first choice.
Chromaticity diagram analysis of patients operated
with TB showed slightly higher CIELAB distances
between ERM and the underlying unstained tissue
compared with the ILM and subjacent unstained
retina, although a t-test showed no statistical difference
between both groups. Average CIELAB distance was
8.51 for the ERM group and 7.09 for the ILM group,
P = 0.48 (Figure 1).
Comparison of the different vital dyes’ affinities to the
ILM showed similar values for TB compared with BBG
but significantly inferior results when matched with
ICG. Average CIELAB distance was 7.09 for the TB
group, as against 6.81 for the BBG group (P = 0.71) and
15.81 for the ICG group (P = 2.45 · 10−5) (Figure 2).
Chromaticity data for all subgroups revealed a
Gaussian distribution. Comparison of disease subgroup
mean values revealed P values of 0.12 for
subjects operated with TB and 0.52 and 0.98 for eyes
operated with brilliant blue G and ICG, respectively. As
all results were statistically nonsignificant, no further
comparison of subgroups was needed. In particular,
pairwise t-tests and adjustment of P values for multiple
comparison using the Holmes correction method were
not performed because of nonsignificance.
Discussion
Intraoperative staining of the ILM contributes
to making its removal safer, easier, and more
complete.5–8,16 The search for a truly adequate sub-
stance for this purpose is ongoing, however, because
available compounds fail to combine maximum intra-
operative utility with a satisfactory safety profile:
Fig. 1. Trypan blue stains ERM slightly better than the ILM, but sta-
tistical significance is not reached (P = 0.48). The ordinate displays the
CIELAB score (Euclidean distance). The upper and lower margins of
the boxes in this standard box-and-whisker diagram represent the 25th
and the 75th percentile and the central line inside the box the 50th
percentile (median). The whiskers mark the minimum and the maxi-
mum, with some outliers plotted as small circles.
Fig. 2. Trypan blue stains the ILM similarly well as BBG (P = 0.71)
but significantly more weakly than ICG (P = 2.45 · 10−5). The
ordinate displays the CIELAB score (Euclidean distance). The upper
and lower margins of the boxes in this standard box-and-whisker
diagram represent the 25th and the 75th percentile and the central line
inside the box the 50th percentile (median). The whiskers mark
the minimum and the maximum, with some outliers plotted as small
circles.
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• Indocyanine green has been used as an adjunct for
chromovitrectomy for almost a decade17 as it selec-
tively stains the ILM.18 Its staining characteristics are
excellent,19 but numerous reports on toxic side effects
have generated a persistent controversy.20–24 Indocya-
nine green is approved for intravenous use, while its
intravitreal application represents an off-label use.
• Brilliant blue G has recently been approved for
intravitreal use in the European Union. Although
in vitro toxicity has recently been reported,25,26 initial
clinical reports demonstrate favorable anatomical and
functional results with no apparent toxicity.19,27,28
However, while BBG also selectively stains the
ILM,27 staining intensity has been reported to be sig-
nificantly inferior to that of ICG.14,19
• After its recent Food and Drug Administration’s
approval, TB is now also approved for intravitreal
use in both Europe and the United States. Trypan blue
had been used for staining of the anterior capsule in
cataract surgery for over a decade before.29 It displays
outstanding staining of ERMs,30,31 while evidence on
its affinity to the ILM is controversial.13,30,32,33 Trypan
blue is generally recommended for the removal of
epiretinal tissue rather than for ILM peeling itself,34
although several clinical studies suggest that TB may
be more useful for ILM removal than customarily
conceived.31–33,35–37 Retinal toxicity has been occa-
sionally reported from in vitro experiments38 and
in vivo studies,39,40 while other authors found no
indications for in vivo toxicity.16,37,41–43
The presence of ERM overlying the ILM requires
a sequential approach. To this end, the use of multiple
vital stains during the same operation has been
proposed,44,45 where the first dye intends to stain
ERM, while a second dye is injected after the removal
of ERM to stain the ILM. Alternatively, we have dem-
onstrated that sequential peeling may be attained with
the use of a single ILM-specific vital dye. In this case,
circumscribed ERM will be identified as unstained
areas surrounded by tinged ILM. After ERM removal,
the same vital dye is injected a second time, now
having access to the exposed ILM.46
Although chromaticity measurements performed in
this study were based on digital video clips, the
transferal of measurement results into the CIELAB
color space has been recognized to accurately repro-
duce human contrast discrimination capacity.14 CIE-
LAB scores in this study, thus, are a measure of how
well the surgeon will recognize the stained structures
intraoperatively.
While affinity of TB to ERM is uncontroversial, our
finding that it stains the ILM equally well is in accord
with those who have previously advocated TB for ILM
removal33,36,37 but is at variance with others who
oppose a TB affinity to acellular structures, including
the ILM.30,47 Whether TB stains the ILM directly or
whether fine cellular debris overspreading the ILM is
responsible13,47 is to be elucidated in the future.
Although TB is shown to stain the ILM as well as
BBG in this study, somewhat more adverse safety
profile of TB needs to be pondered, when considering
it as an alternative to BBG in chromovitrectomy.
Safety concerns may be, at least in part, explained by
considerably higher concentration of TB compared
with BBG. The concentration of a vital dye necessary
to allow useful intraoperative staining depends on the
proportion of the substance’s spectral absorption max-
imum located within the spectrum of visible light.48
While there is large overlap between the spectrum
of visible light and absorption of BBG, including the
absorption maximum,49 the TB absorption spectrum is
gently displaced toward longer wavelengths,50 requir-
ing higher concentrations for equal staining results.
Absorption of ICG spectrum is predominantly located
in the near infrared spectrum,48 and its outstanding
staining characteristics are reached at the expense of
high dye concentrations and the notable toxicity profile.
In the light of the correlation between dye concentra-
tion and intraocular toxicity, the use of a mixture of BBG
and TB at low concentrations might improve results over
the use of the individual agents. A combination vital dye
containing BBG at 0.025% and TB at 0.15% has
recently been launched (Membrane Blue Dual; DORC
International BV). Initial practical experiences with this
compound are encouraging in our hands, and first
in vitro studies report good safety.26 Clinical or experi-
mental reports are not yet available at this time.
Trypan blue distinguishes itself from all other
available intravitreal dyes by staining both ERM and
ILM. Trypan blue can, thus, be seen as an interesting
alternative to BBG for the removal of both ERM and
ILM (double peeling). Trypan blue offers the surgeon
the advantage that all tissues to be removed can be
stained with the same vital dye.
The patient population used in this study consists of
a group of four related diseases, whose configurations
might influence staining characteristics. However,
subgroup analyses of variance revealed that staining
was not affected by the underlying pathology in any of
the vital dye groups with P values of 0.12 for subjects
operated with TB and 0.52 and 0.98 for eyes operated
with brilliant blue G and ICG, respectively.
As a limitation to our methodology, we believe that
the affinity of TB to cellular matter may result in less
homogeneous staining of ERM than that of the ILM,
sometimes resulting in a reticular pattern that may, in
fact, facilitate recognition in a way not represented by
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average contrast scores based on the entire ROIs. A
slightly longer retinal exposure time and cooler TB
baseline temperature favoring sinking of the substance
onto the retina may be other factors that may have
favored TB performance in relation to BBG.
All BBG was from batches made before the addition
of deuterium, which has been recently added to the
formula by the manufacturer to promote descent of the
solution within the vitreous cavity and, thus, contact
between the dye and the posterior pole ILM. In fact,
first clinical reports observed improved staining of the
ILM with this modified BBG.51
An important restriction has been that the classifi-
cation of ERM versus ILM was based exclusively on
the characterization of video material and that histo-
logic confirmation was not available because of the
retrospective nature of this study. We believe, how-
ever, that postoperative review of the videos with the
surgeon guaranteed maximum clinical accuracy and
have demonstrated previously that visual distinction of
ERM and ILM based on staining comportment is
possible with a high degree of precision.46
There are a range of chromovitrectomy protocols
currently in use, and our results are based on findings
from the specific methodology of this study. Different
protocols might generate divergent findings:
Trypan blue was injected under BSS and removed
after 10 seconds. Application under BSS is recom-
mended by some groups in the literature,52 but advo-
cates of an application under air can also be
found.8,16,53 The storage at 4°C is intended to improve
TB descent within the vitreous cavity. Brilliant blue G
washout, however, was performed immediately in our
patient sample, as recommended in the manufacturer’s
instruction leaflet, and BBG was conserved at room
temperature according to the hospitals’ protocols. As
ICG is not approved for intravitreal use, explicit refer-
ences for its usage are not obtainable. For the current
patient sample, ICG strength and intravitreal retention
time were chosen according to the clinical protocols of
the participating study centers. Indocyanine green was
applied under BSS at a concentration at the upper limit
of the 0.05% to 1.25% range described in the litera-
ture, with or without fluid–air exchange.23,54 Published
ICG washout times vary from immediate removal to
180 seconds,23,54,55 while 1 minute was used in our
sample. The effect of variations in clinical application
protocols on contrast strength has yet to be evaluated,
but improved staining is expected with higher concen-
trations and extended exposure times based on preclin-
ical findings.56 The distance of the tip of the needle
from the macula during dye injection may also influ-
ence staining outcome. Although the injection needle
was positioned in the central vitreous by all surgeons,
an exact distance from the fovea was not specified in
this retrospective study and may account for some
degree of variability.
The bias chromaticity measurements may suffer
based on the choice of the intraocular light source as
has been discussed previously.14 All interventions in
this study were carried out using the same mercury
vapor–based endoillumination system, allowing com-
parison between subjects.
About the lens status, chromaticity scores may have
been somewhat influenced by different light-filtering
effects produced by the presence of a natural or an
artificial lens. However, only 4 of 51 patients were
phakic: 2 from the BBG group and 2 from the ICG
group. All phakic patients presented average CIELAB
score values within the 25th to 75th percentile so that
the effect appears to be negligible, although statistical
proof cannot be provided because of small sample size.
Future prospective trials with larger sample sizes
should investigate whether variables such as patient
age, lens status, dye concentrations, dye temperature,
exposure time, distance of the injection needle from the
fovea, application with or without fluid–air exchange,
and choice of endoillumination influence staining per-
formance of TB. Further research is also warranted to
analyze whether BBG and TB staining properties are
additive and, if so, whether the simultaneous applica-
tion of both substances represents a useful technique to
improve ILM staining at low dye concentrations.
Conclusions
Trypan blue represents a suitable vital dye for
chromovitrectomy in general and for sequential mac-
ular surgery in particular. For chromovitrectomy, its
approval status and ILM staining characteristics make
it a worthwhile alternative to BBG. Trypan blue is
highly valuable in sequential ERM and ILM peeling,
as its additional affinity to ERM allows delineation of
all the target tissues of this operation. Occasional
indications of retinal toxicity need to be carefully
monitored.
Key words: TB, trypan blue, BBG, brilliant blue G,
chromovitrectomy, contrast perception, epiretinal
membranes, ERM, internal limiting membrane, ILM.
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